Background Inflamed environments are typically hypercellular, rich in pro-inflammatory cytokines, and profoundly hypoxic. While the effects of hypoxia on neutrophil longevity and function have been widely studied, little is known about the consequences of this stimulus on eosinophils.
Introduction
Eosinophils are innate immune cells involved in allergic inflammation. While recent studies have highlighted certain beneficial effects of eosinophils (e.g. to support muscle regeneration [1] , maintain bone marrow plasma cell numbers [2] , regulate the biogenesis of beige fat [3] , and promote respiratory syncytial virus clearance [4] ), most indicate a pathogenic role for these cells in inflammation [5] . The damaging potential of eosinophils has been attributed to their ability to generate and secrete an array of highly histotoxic products, most of which are contained within pre-stored granules; this is achieved by either exocytosis, cytolysis or piecemeal †These authors made an equal contribution.
degranulation [6] . These processes permit the selective release of a highly active 'secretome' consisting of cationic proteins, pro-inflammatory cytokines, bioactive lipids, and reactive oxygen intermediates. In addition, Charcot Leyden crystals (CLCs) are eosinophil-derived bipyramidal structures found in tissues and body fluids of patients suffering from eosinophilic inflammation, typically affecting the airways [7] . While the dominant CLC protein (galectin-10) has now been recognized as a member of the lectin family [8] , the processes leading to CLC formation remain poorly understood. Moreover, the CLC protein appears to be highly pro-inflammatory; for example, galectin-10 mRNA is overexpressed in aspirin-induced asthma and CLCs have been shown to damage respiratory epithelium and increase vascular permeability [9] .
Allergic inflammation is thought to delay the capacity of eosinophils to undergo constitutive apoptosis [10] , and in animal models, accelerating eosinophil apoptosis promotes the resolution of allergic inflammation [11] . Corticosteroids, working through the glucocorticoid receptor (GR), are highly efficient in suppressing allergic inflammation, in part through their capacity to suppress degranulation and secretory responses and potentially also through their ability to drive eosinophil apoptosis [12, 13] . However, despite the exquisite sensitivity of eosinophils to the pro-apoptotic effects of GR agonists in vitro, a significant subset of patients with eosinophilic inflammation exhibit glucocorticoid-resistant disease; such individuals present a major therapeutic conundrum and utilize disproportionate healthcare resources [14] . Of note, much of the experimental work undertaken to define the biology of eosinophils has been conducted under ambient oxygen concentrations, typically 21 kPa. This relatively 'hyperoxic' state may have little relevance to the physiological PO 2 these cells encounter in vivo, with both sterile and nonsterile inflammation able to reduce the level of tissue oxygenation still further, often to PO 2 values below 1 kPa; this predicates the need for myeloid cells to operate efficiently under hypoxic conditions [15] [16] [17] .
We have shown that neutrophils express the oxygensensing prolyl hydroxylase enzymes PHD1-3 and the transcriptional factors HIF-1a and HIF-2a, and although well adapted to survive under hypoxia, are extremely sensitive to the ambient PO 2 [15] . Hence, a drop in oxygen levels to 3 kPa (which equates to physiological oxygen tensions in the skin [18] , gut [19] , and bone marrow [20] ) causes a marked inhibition of neutrophil NADPH oxidase-dependent ROS generation and bacterial killing [21] . Hypoxia also impairs spontaneous neutrophil apoptosis, the latter through a HIF-1a-and NF-jB-dependent pathway [15] .
In contrast, eosinophil responses under hypoxia have been far less studied. HIF-1a and HIF-2a are both expressed in murine eosinophils and appear to regulate eosinophil chemotaxis [22] and in vitro, hypoxia has been reported to up-regulate the inhibitory receptor CD300a, enhance eosinophil viability, and cause a small increase in basal IL-8 and VEGF release [23, 24] . However, the effects of hypoxia on the pro-apoptotic and anti-inflammatory effects of corticosteroids on eosinophils are unknown. This question has important biological relevance, not only because of the hypoxic environment commonly encountered by eosinophils in vivo, but because of reports in other cell types that hypoxia can induce a state of glucocorticoid resistance [25] .
Using ultra-pure human blood eosinophils, we now show that hypoxia is a potent stimulus of spontaneous and agonist-stimulated IL-8 release, an effect that is most evident in cells purified from atopic and asthmatic donors. We also report for the first time that culture of human eosinophils results in overt CLC formation only when cells are purified from atopic donors and, perhaps more critically, when these cultures are performed under hypoxic conditions (PO 2 3 kPa). In addition, we demonstrate that hypoxia antagonizes the normal pro-apoptotic effect of dexamethasone and as a consequence reduces the extent of efferocytosis by monocyte-derived macrophages. Mechanistically, the capacity of hypoxia to inhibit eosinophil apoptosis appears to relate to the ability of this stimulus to 'out-compete' the normal pro-apoptotic effect of corticosteroids, as GR-mediated nuclear signalling is preserved under hypoxia [26] . These studies illustrate the significant effects of physiologically and pathologically relevant levels of hypoxia on eosinophil function, and the capacity of hypoxia to attenuate one of the major antiinflammatory effects of corticosteroids.
Methods
These studies were approved by the Cambridge Research Ethics Committee, UK (06/Q0108/281); written informed consent was obtained from all participants.
Isolation of human peripheral blood neutrophils and eosinophils
Human peripheral blood neutrophils were purified from healthy donors using dextran sedimentation and discontinuous plasma-Percoll gradients as detailed [27] . Human eosinophils were isolated from healthy volunteers, mildly atopic donors (with appropriate history and a positive skin prick test to one or more aeroallergens), and individuals with asthma (physician-diagnosed on Step for neutrophils and >99% for eosinophils (Fig. 1a) . Both of these isolation methods have been demonstrated by our group to induce minimal cell priming/activation as judged in neutrophils by the lack of basal shape change or oxidative burst to fMLP [28] and in eosinophils by unperturbed cell surface expression of CD69, CD44, CD81, and CD66b, shape change, EM-assessed granule morphology, and eosinophil-derived neurotoxin (EDN) release [29] .
Hypoxic culture of eosinophils and neutrophils
Purified eosinophils were re-suspended at 1-2 9 10 6 cells/mL in RPMI supplemented with 10% (v/v) autologous serum, 100 U/mL streptomycin, and 100 U/ mL penicillin. Neutrophils were re-suspended at 5 9 10 6 cells/mL in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% (v/v) autologous serum, 100 U/mL streptomycin, and 100 U/mL penicillin or Dulbecco's phosphate-buffered saline (PBS) containing CaCl 2 and MgCl 2 (PBS+). Apoptosis assays were undertaken in a final volume of 150 lL in flatbottomed 96-well (ultra-low attachment) Costar TM plates.
Normoxic incubations utilized media equilibrated in a humidified 5% CO 2 /air incubator (representing 19-21 kPa oxygen), whereas a hypoxic environment (typically an atmospheric oxygen concentration of 0.8%, Expression of Glut1 and BNIP3 both served as positive controls for HIF-regulated transcripts. Data represent the mean AE SEM of (n) = 3 independent experiments. (e) Neutrophils were pre-incubated with or without the CXCR2 antagonist SB332235Z (100 nM) for 30 min and the degree of chemotaxis towards eosinophil supernatants (derived from healthy controls following 12 h N or H (n = 5)) or IL-8 (100 ng/mL; n = 3) was assessed. Data represent the mean AE SEM number of migrated neutrophils. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns, not significant.
giving a media PO 2 of 2.8 AE 0.1 kPa, (n) = 20, with PCO 2 and pH values matched to the values under normoxic conditions) was achieved by culturing in a Ruskinn Invivo 400 hypoxic incubator. All media were allowed to equilibrate for 3 h prior to use, and hypoxia was confirmed using an ABL5 blood gas analyser (Radiometer, Denmark). CO 2 settings were titrated to ensure maintenance of a physiological pH and varied according to the buffering system. The induction of hypoxia at a cellular level was confirmed by showing stabilization of eosinophil HIF-2a using anti-HIF-2a (Novus Biologics, Abingdon, OXon, UK) (Fig. 1b) . Despite repeated attempts, HIF-1a could not be reliably detected by Western blot in human eosinophils.
Western blot analysis
Following culture of 1-5 million eosinophils/well in ultra-low attachment six-well plates for 6 h under normoxia and hypoxia, the supernatants were removed and cells were lysed with 100 lL of radioimmunoprecipitation assay (RIPA) buffer containing protease and phosphatase inhibitors (150 mM sodium chloride, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS (sodium dodecyl sulphate), and 50 mM Tris, pH 8.0 containing cOmplete TM , EDTA-free Protease Inhibitor Cocktail Tablets, Roche). The plates were snap-frozen using dry ice in industrial methylated spirit (IMS) and stored at À80°C until required, then later scraped and the lysates sonicated and analysed for protein content. Freshly isolated cells were re-suspended in the appropriate supplemented medium at 1-5 million eosinophils/tube and pelleted at 256 g for 5 min at 4°C. Pellets were also re-suspended in 100 lL of RIPA buffer before being snap-frozen. Samples were prepared by mixing with LDS sample buffer (49) and heated to 70°C (for HIF1/2a detection on Tris-acetate gels) for 10 min and allowed to cool to room temperature prior to loading and subsequent SDS-PAGE analysis using Tris-acetate 3-15% gels. Membranes were probed for HIF stabilization using anti-HIF-1a anti-HIF-2a antibodies (Novus Biologics) using the enhanced chemiluminescence (ECL) kit (Amersham Pharmacia Biotech, GE Healthcare) and normalized against p38 protein, as previously described [30] .
Assessment of apoptosis
Eosinophil and neutrophil apoptosis was assessed using cell morphology and Annexin V/PI flow cytometry as described [31] . As acidic microenvironments have been shown to enhance the viability of eosinophils, the tissue culture media contained 25 mM Hepes and the pH was monitored throughout the experiment [32] . Inhibitors and compounds used to investigate the effects of hypoxia on eosinophil lifespan and function included NF-jB inhibitor GSK657311A, Class 1A PI3-kinase inhibitor 987740A, CXCR2 antagonist SB-3322357, and the GR modulator GRT10 (all gifted from Dr Stuart Farrow, GSK); a pan-PI3K inhibitor LY294002 (Calbiochem, Nottingham, UK); and JNK inhibitor SP600125 (Sigma, Dorset, UK).
Assessment of eosinophil activation
Quantification of CLC formation. Actin polymerization. Eosinophils were re-suspended at 1 9 10 6 /mL in PBS without cations (PBS-) and incubated in normoxic and hypoxic PBS and left for 1 h prior to stimulation. Cells were then stimulated with fMLP (100 nM), eotaxin (100 nM), or vehicle for the time-points indicated and fixed in 4% formaldehyde. After 1 h, 100 lL NBD buffer (NBD-phallacidin in 1.5 mL of absolute methanol, 37% formaldehyde, PBS, 0.2 mg/mL lysophosphatidylcholine) was added and the cells were incubated in the dark for a further hour. Cells were analysed on a Fortessa (BD) flow cytometer using excitation with the 488-nm laser and emission was measured at 525 nm (green fluorescence/FL1) [33] .
Analysis of CD69 cell surface expression. Freshly isolated eosinophils were suspended in supplemented RPMI at 2 9 10 6 cells/mL and incubated in either a normoxic or hypoxic environment. Cells were washed in FACS buffer (PBS, 2 mM EDTA, 0.5% BSA, and 0.1% sodium azide) and re-suspended in 100 lL FACS buffer containing 2.5 lL CD69-FITC-conjugated antibody or IgG isotype control (2.5 lL FITC-mouse IgG1j). The samples were incubated on ice for 30 min in the dark, washed, and re-suspended in 500 lL FACS buffer prior to analysis.
Macrophage phagocytosis assays
Phagocytosis was measured by both light microscopy and flow cytometry. Human monocytes isolated over discontinuous plasma-Percoll gradients were cultured in 24-well tissue culture plates for 7 days in RPMI with 100 ng/mL M-CSF to yield monocyte-derived macrophages (MDMφ). For light microscopy assessment, 2 9 10 5 MDMφ in RPMI were incubated with 6 9 10 20-24 h in vitro) for 1 h (37°C, 5% CO 2 ) in a normoxic (21%) or hypoxic environment (0.8%), and then fixed with 2.5% glutaraldehyde. The cells were stained for myeloperoxidase (MPO) with 0.1 mg/mL dimethoxybenzidine and 0.03% (v/v) hydrogen peroxide in PBS (MDMφ are MPO negative) [34] . The percentage of macrophages that had ingested one or more apoptotic granulocyte was quantified by examining a minimum of 300 cells in duplicate wells. To confirm that the apoptotic neutrophils or eosinophils had been internalized, trypsinized cells were cytospun, stained with DiffKwik TM , and examined under oil immersion. For flow cytometric quantification of phagocytosis, MDMφ (2 9 10 5 /mL/200 lL/well) were prepared as above. Normoxic or hypoxic eosinophils (1 9 10 7 /mL in RPMI without serum) were stained with CMFDA cell tracker dye (1 lL/10 7 cells) for 15 min at 37°C. The labelled cells were washed in RPMI and re-suspended at 3 9 10 6 /mL in serum-free RPMI. MDMφ (6 9 10 5 /well) were washed and co-incubated with 200 lL of CellTracker Green CMFDA-labelled apoptotic eosinophils. Following co-incubation for 1 h at 37°C under a normoxic environment or hypoxic environment, media were replaced with 0.5 mL trypsin-EDTA for 15 min at 37°C and 15 min at 4°C. Vigorous pipetting was performed to ensure detachment of all adherent cells and the extent of MDMφ phagocytosis assessed by flow cytometry. MDMφ were identified and gated according to their forward and side-scatter characteristics; MDMφ that had ingested apoptotic eosinophils showed an increase in green fluorescence, becoming FL-1 positive [34] .
Cytokine and growth factor ELISAs and quantification of EDN release
Eosinophils (10 6 /ml) were incubated under normoxic or hypoxic conditions for 12 h and supernatants collected, (pooled 2000 g, 6 min) and stored at À80°C. Release of cytokines including IL-5, IL-6, IL-8, IL-10, and GM-CSF were measured by ELISA using 96-well Microlon â plates according to the manufacturer's instructions (Qiagen, Crawley, UK). Biotinylated secondary polyclonal antibody was measured using streptavidin-conjugated alkaline phosphatase, and the plates were developed with p-nitrophenylphosphate and read at k405 nm using a Bio-Rad 550 micro-plate reader. Additional confirmation of cytokine release from eosinophils was undertaken using Qiagen Multi-Analyte ELISArray plates used in accordance with the manufacturers' guidelines. EDN release was measured by ELISA, according to the manufacturer's guidelines (Immundiagnostik-AG, Bensheim, Germany; lower limit of detection 0.164 ng/mL). Data were analysed using Microsoft Plate Manager (MPM) 1.57 software.
Neutrophil chemotaxis assays
Supernatants from normoxic or hypoxic eosinophils (or IL-8, 100 ng/mL) were placed underneath a NeuroProbe ChemoTx â disposable 96-well filter; freshly isolated neutrophils (5 9 10 6 cells/mL in IMDM plus 0.1% autologous serum) were added on top of the filter and incubated for 90 min at 37°C in a humidified normoxic incubator. The suspension from each bottom well was collected and the wells were washed twice with warm EDTA-trypsin. Cell migration was assessed by haemocytometer cell counting.
Measurement of dexamethasone-and hypoxia-regulated gene expression
For RNA isolation, granulocytes were cultured in sixwell plates at 2 9 10 7 per well (neutrophils) or 1-5 9 10 6 per well (eosinophils), harvested, and the cell pellets were re-suspended in 1 mL TRIZOL â (Invitrogen); following chloroform extraction and isopropanol precipitation, the RNA pellet was washed 92 with 1 mL ice-cold 70% (v/v) ethanol, air-dried, re-suspended in 100 lL of nuclease-free water (Promega, Delta House, Southampton, UK), and a RNA clean-up and DNase digest were performed using RNeasy micro-column kit (Qiagen). A high-capacity cDNA kit (Applied Biosystems) was used to generate cDNA using 1 lg of total RNA using the following programme settings: 25°C for 10 min, 37°C for 2 h, 85°C for 5 min and 4°C on hold; RNA preparations were stored at À80°C.
Changes in gene expression were assessed by qPCR using SYBR â Green Jumpstart TM Taq Readymix TM (Sigma), Rox reference dye (Invitrogen) and primers obtained from Qiagen (Table S1 ). The reactions were performed on a StepOnePlus TM (Applied Biosystems) real-time PCR machine or a 384-well 7900HT fast realtime PCR machine (Applied Biosystems). Primer efficiency was optimized to obtain the following PCR settings: 2 min at 95°C for Taq polymerase activation, 40 cycles of denaturation for 30 sec at 95°C, annealing for 30 sec at 55°C, and extension for 30 sec at 72°C. Cycle threshold (C t ) values from control and experimental sample sets were normalized to appropriate housekeeping genes (beta-2-microglobulin/YMHAZ/18s) (DDC t = DC t , sample -DC t ) and the relative change in target gene expression (fold change) analysed using the 2 ÀDDC T method [35] .
Data analysis
The results are reported as the mean AE SD or SE of (n) independent donor experiments with each treatment performed in triplicate for neutrophils and duplicate for eosinophils unless otherwise stated. Data were analysed using the GraphPad Prism statistical analysis package. Paired t-tests were used to compare the means from two groups when samples were obtained from the same donor and were of Gaussian distribution. For the comparison of three or more groups, one-way ANOVA with a post-Tukey's or Dunnett's test was performed or twoway ANOVA was used when more than one variable was assessed, with a post-Tukey's or Dunnett's test for multiple comparisons. A value of P < 0.05 was considered significant.
Results
Hypoxia stimulates basal and agonist-mediated IL-8 release from human eosinophils
To determine whether hypoxia influences the release of inflammatory cytokines, human eosinophils were isolated and the supernatants collected following 12 h of normoxia or hypoxia culture. From the panel of chemokines and cytokines examined, enhanced IL-8 levels and MIP-1b were observed in all subjects following hypoxic culture (Figs 1c and S1 ). Furthermore, the extent of IL-8 release correlated with the clinical diagnosis, with eosinophils from individuals with atopy and asthma having the highest levels of IL-8 secretion under hypoxia (Fig. 1c , values for asthmatic subjects are within the dashed box).
To investigate whether the enhanced release of IL-8 under hypoxia involved enhanced transcription, eosinophils were cultured under normoxia or hypoxia and the level of IL-8 mRNA was assessed (Fig. 1d) . Hypoxia led to stabilization of eosinophil HIF-2a protein (Fig. 1b) and up-regulation of HIF-1a-regulated transcripts BNIP3 and GLUT1 mRNA, demonstrating activation of both HIF-1a and HIF-2a-dependent signalling pathways; in contrast however, hypoxia had no effect on IL-8 mRNA levels (Fig. 1d) . Hence, the increased IL-8 release evident under hypoxia may reflect enhanced release of pre-formed IL-8 as opposed to de novo biosynthesis; attempts to explore this further using transcriptional and protein synthesis inhibitors were thwarted by the extreme sensitivity of eosinophils to agents such as cycloheximide, which induces a profound pro-apoptotic response, even at concentrations of 0.1 lg/mL.
To determine whether the IL-8 released under hypoxia was biologically active, eosinophil-derived supernatants were assessed in a neutrophil chemotaxis assay using rhIL-8 as a positive control. As shown in Fig. 1e , supernatants derived from eosinophils (from both healthy and atopic donors) cultured ex vivo under hypoxia induced neutrophil chemotaxis to the same extent as a predetermined optimal concentration of rhIL-8, and this was inhibited by the CXCR2 antagonist SB332235Z. A similar trend was observed for supernatants derived from eosinophils incubated under normoxia (Fig. 1e) . These data suggest that particularly within the setting of hypoxic inflammation, eosinophils may be a significant source of IL-8, capable of promoting neutrophil influx.
Effects of hypoxia on eosinophil degranulation and polarization
Piecemeal degranulation is a unique eosinophil secretory mechanism, which results in a selective liberation of cytokines and chemokines and leads to a stimulusspecific eosinophil secretory profile [27, 36] . In view of the effect of hypoxia on eosinophil IL-8 release, we investigated additional biologically relevant secretory products and the activation status of eosinophils following hypoxic incubation.
Charcot Leyden crystals are a marker of eosinophil involvement in inflammatory reactions, and persist after eosinophil death/clearance. However, their genesis is poorly understood. Eosinophils derived from healthy volunteers cultured under either normoxia or hypoxia failed to show any CLC formation; in contrast, eosinophils derived from atopic or asthmatic donors cultured under hypoxia for over 24 h showed prominent CLC formation (Fig. 2a,b) , which was not observed under normoxic conditions. Co-incubation of eosinophils with dexamethasone (100 nM) did not affect basal or hypoxia-induced CLC formation (Fig. 2b) . These data support the view that eosinophils from atopic donors differ from healthy donor cells and suggest that hypoxia is an important and previously unrecognized factor in CLC formation.
The conversion of monomeric to filamentous actin (F-actin) is a central process underlying granulocyte motility and exocytosis. Eosinophils cultured under hypoxia exhibited a greater degree of eotaxin-induced actin polymerization compared to cells stimulated under normoxia (Figs 2c and S2) . Although the fold increase in total cell F-actin content is small, localized actin polymerization in discrete areas of the cell is essential for vesicle fusion; hence, small focal increases may have profound biological relevance. Given this, we predicted that hypoxia might impact globally on eosinophil secretion. However, as shown in Fig. 2d , the extent of IL-5-induced eosinophil-derived neurotoxin (EDN) release was actually attenuated under hypoxia; this inhibitory effect was seen in eosinophils derived from both healthy volunteers and asthmatic subjects (Fig. 2d and data not shown). Likewise, hypoxia had no effect on basal or GM-CSF-stimulated CD69 expression (data not shown), which is also stored in eosinophil granules and up-regulated on the eosinophil surface following cytokine stimulation or whole lung antigen challenge [37] . Together, these data demonstrate that hypoxia has a nuanced effect on eosinophil secretion, specifically increasing IL-8 release and CLC formation from eosinophils derived from asthmatic/atopic but limiting the liberation of EDN.
Hypoxia promotes eosinophil survival and reduces phagocytic uptake by macrophages
Although debated, impaired eosinophil apoptosis and defective phagocytic clearance (efferocytosis) have been proposed to contribute to the persistence of allergic inflammation. To determine the effects of hypoxia on eosinophil lifespan, these cells were cultured in normoxia or hypoxia in the absence or presence of IL-5, a known pro-survival stimulus. The percentage of apoptotic eosinophils measured by flow cytometry (Fig. 3a) and morphology (Fig. 3b) at 24 h was markedly reduced by hypoxia, to a level comparable to that seen with IL-5. Analysis of the supernatants derived from hypoxia-cultured eosinophils showed no evidence of IL-5 or GM-CSF release, suggesting that this was not due to an autocrine effect of these agents (data not shown).
To determine whether the pro-survival effect of hypoxia on eosinophils might impair eosinophil clearance, the degree of eosinophil efferocytosis by M-CSFdifferentiated MDMφ was assessed. As shown in Fig. 3c , MDMφ uptake of eosinophils was markedly reduced when the eosinophils presented had been pre-incubated under hypoxia rather than normoxia for the previous 24 h. A subset of MDMφs were also placed under hypoxia for the duration of the efferocytosis assay, but this had no effect on their capacity to ingest apoptotic eosinophils (Fig. 3c ). This contrasts with the ability of hypoxia or hypoxia mimetics to blunt the capacity of MDMφs to efferocytose apoptotic neutrophils (see Fig. S3 ). To confirm that we were examining true efferocytosis, a subset of MDMφs were trypsinized at the end of the incubation period and examined by light microscopy, which clearly showed apoptotic cells contained within MDMφ (data not shown). These data indicate that hypoxia impairs eosinophil apoptosis and thus clearance in vitro. Data represent the mean AE SEM of (n) = 3 independent experiments. */#P < 0.05; **P < 0.01; ***P < 0.001; ****/ ####P < 0.0001 (* relative to N control; # relative to N equivalent).
Hypoxic-mediated eosinophil survival is regulated by NF-jB and PI3-kinase
To explore the role of NF-jB in conferring the pro-survival effect of hypoxia on eosinophils (as previously demonstrated in neutrophils [15] ), eosinophils were incubated with the selective IKKa inhibitor GSK657311A (1-30 lM; GSK, Stevenage, UK); comparative studies were also undertaken with the PI3-kinase inhibitor LY294002 (Calbiochem, Nottingham, UK), the more selective PI3-kinase Class I inhibitor 987740A (GSK), and the JNK inhibitor SP600125 (Sigma-Aldrich, Dorset, UK). Unlike the effects seen in neutrophils, the IKKa inhibitor GSK657311A (Fig. 4a) and PI3-kinase inhibitor 987740A (from GSK) (Fig. 4b) both caused a concentration-dependent induction of constitutive apoptosis in eosinophils even under normoxic conditions, suggesting that both signalling pathways play a tonic survival role in these cells [15, 38] . Despite this, hypoxic eosinophil survival was attenuated by GSK657311A (at 30 lM), LY294002 (at 10 lM), and 987740A (at 10 lM), suggesting a role for both NF-jB and PI3-kinase signalling in this response (Fig. 4a,b) . JNK pathway inhibition with SP600125 had no effect on eosinophil apoptosis under either normoxia or hypoxia (Fig. 4b) .
Hypoxia attenuates dexamethasone-induced eosinophil apoptosis
Having established that hypoxia has a selective effect on eosinophil secretion and induces a marked survival response, we wished to assess whether hypoxia affected the capacity of corticosteroids to induce eosinophil apoptosis. Given that low oxygen tensions have been associated with reduced GR expression and function in other cells [39] , we predicted that GR-induced eosinophil apoptosis might be impaired under hypoxia. As shown in Fig. 5a -d, precisely this effect was seen, with hypoxia causing a profound suppression of the normal concentration-dependent, pro-apoptotic effect of dexamethasone. This was evident using either morphology or AnV/PI-binding to quantify apoptosis, was additive to the survival effect of IL-5, and was observed for up to 72 h of culture (Fig. 5d) ; these data also confirmed the ability of the GR antagonist RU486 to inhibit the pro-apoptotic effect of dexamethasone (Fig. 5a) . Remarkably, the combination of IL-5 and hypoxia resulted in over 80% eosinophil survival even after 120 h in culture compared to 100% apoptosis/necrosis of eosinophils under normoxic conditions (Fig. 5d) . Hypoxia also blocked the capacity of other high potency GCS (e.g. fluticasone fumarate) to induce eosinophil apoptosis (Fig. 5b) . Of note, the hypoxic inhibition of steroid-induced eosinophil apoptosis could be fully recapitulated by the hypoxic mimetics DFO and DMOG (Fig. 5e) .
Mechanism of hypoxia-mediated inhibition of dexamethasone-induced eosinophil apoptosis
From the above experiments, we hypothesized that hypoxia might affect the expression or function of GR in eosinophils. Surprisingly however, dexamethasone mediated up-regulation of Gilz, a process that is fully GR dependent [40] and was entirely preserved under hypoxia (Fig. 6a) . In these experiments, Glut1 expression was used as a positive control for hypoxia, while Ijb expression was used as a negative control. This indicates that an intact GR-GRE axis is maintained in these cells and that hypoxia operates in a parallel but dominant manner to suppress steroid-induced eosinophil apoptosis. Finally, to address whether the pro-apoptotic effect of corticosteroids in eosinophils is mediated via GRtransrepression or GR-transactivation, we examined the effects of a newly described GR modulator (GRT10), which has been reported to display selective GR-transrepressive effects [41] . Under normoxia, GRT10 also caused a concentration-dependent increase in eosinophil apoptosis (Fig. 6b, EC 50 2 nM) (and suppressed neutrophil apoptosis; see Fig. S4a ), supporting the view that the pro-apoptotic capacity of GC may be mediated via a GR-transrepressive effect. However, GRT10 was unable to promote eosinophil apoptosis under hypoxia, at any of the concentrations tested, suggesting either that hypoxia renders eosinophils insensitive to the Fig. 4 . Hypoxia-mediated eosinophil survival is regulated by NF-jB and PI3-kinase. Eosinophil apoptosis was assessed after 24 h culture under normoxia or hypoxia in the presence or absence of (a) the NFjB inhibitor GSK657311A (1-30 lM), or (b) the Class 1A PI3-kinase inhibitor 987740A (1-10 lM), a pan-PI3K inhibitor LY294002 (LY; 10 lM), or the JNK inhibitor SP600125 (SP6; 10 lM). Data represent the mean AE SEM of data from (n) = 4 independent experiments. **P < 0.01, ***P < 0.001 relative to N control; 6 ¼P < 0.05, 6 ¼ 6 ¼P < 0.01 relative to N equivalent; #P < 0.05, ###P < 0.001 relative to H control. , and DMOG (100 lM) for 24 h. All data (except (d)) represent mean AE SEM of (n) = 4 independent experiments; *P < 0.05, **P < 0.005, ***P < 0.001 relative to N control; ##P < 0.01, ####P < 0.0001 relative to the N equivalents.
pro-apoptotic effects of GRT10, or like dexamethasone, that the marked hypoxic pro-survival effect is sufficient to override any pro-apoptotic signalling.
Discussion
Inflammatory sites, including the airway wall [42, 43] , are often profoundly hypoxic. This results from a combination of vascular damage, the build-up of inflammatory debris, enhanced cellular metabolism, and increased oxygen extraction due to activation of NOX2 [44] . In this study, we aimed to define the effects of hypoxia on eosinophil lifespan and function, and glucocorticoid sensitivity. We confirm that hypoxia is a potent pro-survival stimulus for eosinophils as well as for neutrophils. We also show for the first time that hypoxia reduces the ability of glucocorticoids to induce eosinophil apoptosis, inducing a state of apparent or 'quasi'-glucocorticoid resistance. Furthermore, hypoxic culture of eosinophils promotes the release of IL-8 to levels capable of inducing neutrophil chemotaxis and, in cells from atopic donors, supports the formation of CLC. These data indicate that hypoxia can augment a number of potentially detrimental eosinophil functions and promote neutrophil influx. Hypoxia-induced IL-8 secretion has been reported in cancer [45] , endothelial cells [46] , epithelial cells, and pulmonary fibroblasts [47] as well as macrophages [48] . Consensus sequences for multiple transcription factors (including AP-1, NF-jB, and HIF-1a) are present in the IL-8 promoter region, enabling context-and celldependent IL-8 expression [45, 49] . In agreement with previous results [24] , we show that hypoxia induces release of IL-8 from eosinophils; importantly, we also demonstrate that this is more pronounced in cells from atopic and asthmatic donors and is sufficient to promote neutrophil chemotaxis. In vivo studies support the potential clinicopathological relevance of these findings. In mice, Baek et al. [50] found that combined allergen and hypoxia challenge resulted in a 27-fold increase in the accumulation of peri-bronchial neutrophils that correlated with the release of KC (a functional homologue of IL-8) from peri-bronchial cells, including eosinophils. IL-8 has been detected in airway secretions of patients with acute severe asthma, contributing to neutrophil recruitment in this setting [51, 52] ; indeed, IL-8 was reported to be the only cytokine in BALF which differentiated controlled from uncontrolled asthma and correlated inversely with FEV 1 [52] . Low oxygen tensions do not promote indiscriminate degranulation; indeed, EDN release was actually inhibited by hypoxia. Selective mobilization of pre-formed cytokines from eosinophil granule stores by 'piecemeal degranulation', a process that involves the trafficking of small vesicles directed by SNAP/SNARE interactions, has been observed previously, although not in response to hypoxia; for example, eotaxin can induce the rapid and selective secretion of IL-4 from eosinophils [53] , while IFN-c promotes IL-3 and RANTES release [54, 55] .
We report for the first time that in vitro culture of human eosinophils results in overt CLC formation; intriguingly, this was limited to cells purified from atopic donors cultured. These findings align with earlier reports of CLC formation at sites now recognized to be profoundly hypoxic, for example, within inflamed rheumatoid joints and large carcinomas [56, 57] . Given that reduced oxygen tensions have been measured at inflammatory foci and that hypoxia has been shown to regulate galectin-10 expression, it would be tempting to speculate that hypoxia in this instance predicates CLC formation, contributing to local tissue injury [9] .
The pro-survival effect of hypoxia on neutrophils was first described by our group some years ago [58] ; (b) Fig. 6 . GCS promote eosinophil apoptosis via a GR-transrepressive and oxygen-dependent mechanism. (a) Levels of Gilz (steroid-regulated) and GLUT1 (hypoxia-regulated) mRNA expression relative to IkB levels were examined in eosinophils cultured under N or H for 12 h in the presence of Dex. All transcript levels were normalized to housekeeping control beta-2 microglobulin. (b) Eosinophils were treated with increasing concentrations of the GR modulator GRT10 under N or H for 24 h and assessed for the degree of apoptosis by flow cytometry. Data represent mean AE SEM of (n) = 4 independent experiments; *P < 0.05, **P < 0.01, ***P < 0.001, relative to N control.
however, the effects of hypoxia on eosinophil lifespan have been little studied. Hypoxia has been shown to increase eosinophil viability, at least in part by the induction of the anti-apoptotic protein Bcl-XL [24] . We confirm that hypoxia is a potent pro-survival stimulus for eosinophils, and demonstrate this hypoxic survival is further augmented by cytokines. Cells recruited to inflammatory sites in vivo will undoubtedly experience hypoxia in combination with exposure to pro-inflammatory mediators; in in vitro experiments designed to re-capitulate this environment, we found that ≥ 80% of eosinophils cultured in the presence of both IL-5 and hypoxia were still fully viable after 5 days. Conditions such as asthma and nasal polyposis are characterized by elevated levels of IL-5 and tissue hypoxia, particularly in severe disease [59, 60] . Thus, we speculate that the combination of inflammation and hypoxia may exacerbate disease and delay resolution in this and other settings. The physiological relevance of apoptosis to eosinophil clearance in vivo remains controversial. While apoptotic eosinophils are readily detected in the sputum of patients with asthma, particularly in the steroid-induced resolution phase, detailed biopsy studies have offered little evidence for this event in the airway wall [61] . Whether hypoxia operates to suppress constitutive apoptosis of eosinophils within microenvironments such as inflamed airways, with re-oxygenation on exposure to oxygen in the airway lumen releasing these constraints is unknown, but would be consistent with mouse data where hypoxia increases peri-bronchial eosinophilia post-OVA challenge [50] . Glucocorticoids have dichotomous effects on granulocyte lifespan, promoting neutrophil survival yet inducing eosinophil apoptosis [62] . Although corticosteroids are used to modulate inflammatory cell function within environments that may be profoundly hypoxic, few studies have examined the impact of hypoxia on the effects of these agents. Our observation that the effects of glucocorticoids on granulocyte lifespan are significantly attenuated under hypoxia initially suggested that hypoxia may render these cells steroid insensitive. However, qPCR analysis demonstrated that eosinophils remained intrinsically sensitive to the effects of steroids under hypoxia with dexamethasone retaining the capacity to transactivate genes such as Gilz (Fig. 6) . Moreover, in preliminary experiments, dexamethasone also appears to maintain its transrepressional capacity under hypoxia, causing a reduction (albeit non-significant) in IL-8 release from eosinophils (Fig. S5) . Although in preliminary experiments GRT10 still appeared capable of enhancing some expression of Gilz (regarded as a classically transactivated gene) in eosinophils (Fig. S4b) , similar effects have been seen using other apparently selective glucocorticoid receptor modulators [13] , and may suggest an effect mediated by a non-classical glucocorticoid-responsive element. Thus, hypoxia appears to render granulocytes 'quasi' rather than truly steroid resistant; we speculate that the reason the pro-apoptotic effects of glucocorticoids are no longer evident under hypoxia reflects the overwhelming pro-survival effect induced by hypoxia, that is a simple competitive process between pro-apoptotic corticosteroid-driven pathways and an anti-apoptotic hypoxia-regulated mechanisms; under the experimental conditions used, that the hypoxia-induced survival effect dominates, analogous to the situation previously reported in neutrophils treated with the cytokine GM-CSF [26] .
The physiological and pathological environments encountered by eosinophils in vivo are either known or predicted to be hypoxic compared to arterial or venous blood. The data presented here underscore the sensitivity of eosinophils to ambient oxygen concentration and the significant effects of hypoxia on eosinophil function. These effects were most marked with respect to spontaneous and agonist-stimulated IL-8 and CLC generation, the survival of these cells during in vitro culture, and the attenuation of steroid-induced apoptosis. While this paper does not assess the relevance of these findings to the in vivo situation, the 'hypoxic' PO 2 conditions we used are well within the range of tissue oxygen values recorded, especially under disease conditions.
There has been considerable interest and debate regarding the observation that many eosinophil-targeted therapies appear to be more effective in reducing circulating eosinophil numbers compared to their capacity to reduce eosinophil numbers in tissues. One proposed mechanism in the setting of anti-IL-5 therapies is the reduction in IL-5a receptor expression in bronchoalveolar lavage eosinophils, making these cells far less IL-5 dependent [63] . Our current findings may, however, provide an additional explanation for the enhanced eosinophil survival seen in the inflamed and hypoxic airway wall and the seeming resistance of these cells to the normal pro-apoptotic effect of corticosteroids.
secretion of MCP-1, RANTES, MIP1a, eotaxin and Macrophage-derived chemokine (MDC) are unaltered. Figure S2 . Hypoxia potentiates eotaxin-induced actin polymerization. Figure S3 . Phagocytosis of apoptotic neutrophils using light microscopy and quantitation of MDMφ phagocytosis of apoptotic neutrophils by flow cytometry. Figure S4 . GCs promote neutrophil survival via a GR-transrepressive and oxygen-dependent mechanism. Figure S5 . Effect of hypoxia and dexamethasone on GC-mediated transrepression of IL-8 in eosinophils. Table S1 . Summary of Qiagen primers used for qPCR analysis.
